Impact of glucagon-like peptide-1 receptor agonists on outcomes following anterior cervical discectomy and fusion: a systematic review and meta-analysis.

Eur Spine JAug 8, 2026 (epub)
Clinical ResearchOrthopedic SurgeryEndocrinologyOpen access

Dave Osinachukwu Duru, David Kwan Ryung Lee, Chloe Edmonds et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on outcomes following anterior cervical discectomy and fusion (ACDF) in a cohort of 311,402 patients. The analysis revealed that GLP-1RA users had significantly lower odds of pseudarthrosis at 6 months (OR=0.60), 12 months (OR=0.62), and 24 months (OR=0.67).

Key findings

  • GLP-1RA users had lower odds of pseudarthrosis at 6 months (OR=0.60).
  • At 12 months, the odds of pseudarthrosis were also lower for GLP-1RA users (OR=0.62).
  • At 24 months, GLP-1RA users continued to show lower odds of pseudarthrosis (OR=0.67).
  • Other postoperative complications showed heterogeneous and inconsistent findings.

Why it matters

Understanding the effects of GLP-1RAs on surgical outcomes is crucial for optimizing patient management in those undergoing ACDF, particularly regarding the risk of pseudarthrosis.

Source

Published in Eur Spine J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.